Clinical Trial Update: Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study [Phase 3]

View source ↗

Summary

A Phase III multicenter randomized trial comparing toripalimab consolidation versus observation in unresectable locally advanced esophageal squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 3 | Status: NOT_YET_RECRUITING